The largest database of trusted experimental protocols

20 protocols using cd69 pe cy7

1

Multi-Marker Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for staining: CD4 PerCp-Cy5.5, TCRβ PerCp-Cy5.5, and CD62L APC (TONBO); CD44 FITC, PD-1 (29F.1A12) PE-Cy7, CD69 PE-Cy7, CD5 PerCp-Cy5.5, CD8α Pacific Blue, and TCRβ Pacific Blue (BioLegend); CD44 PE-Cy7, CD8α (APC-eFluor 780), CD4 Qdot606, and Zap70 FITC (Life Technology). In vivo anti-PD (J43) antibody and control IgG were purchased from BioXcell. For intracellular flow cytometry, antibodies against phosphorylated ERKT202/Y204 (197G2), AKTThr308 (C31E5E), and ribosomal protein S6Ser235/236 (D57.2.2E) were purchased from Cell Signaling Technology.
+ Open protocol
+ Expand
2

Hamster PBMC Isolation and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hamster peripheral blood mononuclear cells (PBMCs) were isolated from ethylene diamine tetraceticacid (EDTA) whole blood by overlay on a Histopaque®-1077 density cushion and separated according to manufacturer’s instructions. Tissues were processed into single cell suspensions as described previously (44 (link)). Cells were stimulated for 6 hours with media alone, cell stimulation cocktail (containing PMA-Ionomycin, Biolegend), 1μg/ml SARS-CoV-2 S peptide pool (IDT), or Lassa virus (LASV) GPC peptide pool (IDT) together with 5μg/ml Brefeldin A (Biolegend). Following surface staining with Live/Dead-APC/Cy7, CD4-FITC, CD8-Alexa700, CD94-BV421 and CD69-PeCy7, B220-BV605, CD11b-PerCPCy5.5, and Ly6G-APC (all Biolegend) cells were fixed with 4% paraformaldehyde (PFA). Sample acquisition was performed on a FACSSymphony-A5 (BD), and data analyzed in FlowJo V10. Cell populations were identified by initially gating on Live/Dead negative, doublet negative (SSC-H vs SSC-A). Activation positive responses are presented after subtraction of the background responses detected in the LASV GPC peptide pool-stimulated samples.
+ Open protocol
+ Expand
3

Multicolor Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial antibodies (clones, fluorophores and sources) are as follows: CD3-FITC (145–2C11), CD62L-PE (Mel-14), CD4-PErCP/Cy5.5 (RM4–5), CD8-PerCP/Cy5.5 (53–6.7), CD8-APC (53–6.7), CD209b-APC (22D1), IgM-FITC (II/41), CD4-PE (GK1.5), CD25-AF488 (PC61.5), Streptavidin-PE, CD169-PE/Cy7 (3D6.112) (eBioscience, San Diego, CA); CD11b-FITC (M1/70), CD49d-FITC (R1–2), TCRβ-FITC (GL3), CD21/35-PE (7E9), CD23-APC (B3B4), Ly6G-PE (RB6–8C5), Ly6C-PerCP/Cy5.5 (HK1.4), CD11c-PE/Cy7 (N418), B220-PerCP/Cy5.5 (RA3–6B2), B220-APC (RA3–6B2), B220-APC/Cy7 (RA3–6B2), CD69-BV421 (H1.2F3),CD23-Biotin (B3B4), F4/80-APC (BM8), Ly6G-BV421 (1A8), CD45-Pacific Blue (30-F11), CD45-BV510 (30-F11), CD43-PE (1B11), CD24-PE/Cy7 (M1/69), IgD-Pacific Blue (11–26c.2a), CD69-PE/Cy7 (H1.2F3), IgD-PerCP/Cy5.5 (11–26c.2a), Ly51-AF647 (6C3), CD3-Pacific Blue (17A2), CD3-PE (17A2), TCRγ/δ-biotin (GL3), Streptavidin-PE/Cy7 (Biolegend, San Diego, CA); Siglec-F-PE (E50–2440) (BD Biosciences, San Jose, CA). Samples were preincubated with 1 μg Fc-block (2.4G2 hybridoma; ATCC).
Cells were acquired either on the BD Biosciences LSR Fortessa or with a BD FACScan flow cytometer with DxP multi-color upgrades by Cytek Development Inc. (Woodland Park, NJ) and analyzed using FlowJo software (FlowJo LLC, Ashland, OR).
+ Open protocol
+ Expand
4

Multi-Parameter Flow Cytometry of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each set of patient samples was stained with the following antibodies: CD3-Brilliant Violet 785 (OKT3, Biolegend), CD4-APC/Cy7 (OKT4, Biolegend), CD8-Alexafluor 700 (SK1, Biolegend), CD11b-Brilliant Violet 570 (M1/70, Biolegend), CD19-Brilliant Violet 570 (HIB19, Biolegend), CD34-Brilliant Violet 421 (561, Biolegend), TCR vβ12-PE (VER2.32.1, Beckman Coulter), CD25-Brilliant Violet 711 (BC96, Biolegend), CD69-PE/Cy7 (FN50, Biolegend), OX40-FITC (Ber-ACT35, Biolegend), PD-1-PerCP/Cy5.5 (EH12.2H7, Biolegend), T cell immunoglobulin and mucin-domain containing-3 (TIM-3)-APC (F38-2E2, Biolegend), CTLA-4-PE-CF594 (BNI3, BD Biosciences), C-C motif chemokine receptor 7(CCR7, CD197)-Brilliant Violet 650 (G043H7, Biolegend), and a viability dye (Live/Dead Aqua, Invitrogen). Representative stains are shown in Supplementary Figure 3. All samples were analyzed on the LSRFortessa in the Loyola University Chicago Flow Cytometry Core. The absolute number of TCR-transduced T cells per milliliter (mL) of study blood was estimated by combining percentages of TCR-transduced T cells with counts of total white blood cells from known volumes of whole blood.
+ Open protocol
+ Expand
5

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were extracted from lymph nodes, spleen, or colon tissue digested by collagenase. Isolated cells were stained with following antibodies: CD8-PE-CY7 (Thermo Scientific), CD4-APC-Fire™ 750 (BioLegend), IFN-γ-FITC (BioLegend), IL-17-APC (BioLegend), FOXP3-PE (BioLegend), CD19-PE (BioLegend), NK1.1-FITC (BioLegend), CD11B-APC (BioLegend), Gr-1-FITC (BioLegend), F4/80-PE (BioLegend), CD11C-APC-CY7 (BioLegend), MHC-II-PE/Dazzle™ 594 (BioLegend), CD8-APC (BioLegend), Ki67-PerCP-CY5.5 (BioLegend), Annexin V-FITC (BioLegend), CD103-PE (BioLegend), CD69-PE-CY7 (BioLegend), CD44-PE-CY7 (BioLegend), CD62L-FITC (BioLegend), CD107-FITC (BioLegend), IFN-γ-APC (BioLegend), CD107-PE (BioLegend), IFN-γ-PE (BioLegend), CD3-FITC (BioLegend), CD3-APC/Fire™ 750 (BioLegend), CD8-APC (BioLegend), IFN-γ-PE-CY7 (BioLegend), CD69-APC/Fire™ 750 (BioLegend), Tetramer-SIINFEKL-PE (MBL), p-JNK-PE (Cell Signaling Technology), p-IRAK4-Alexa Fluor 488 (Cell Signaling Technology). Intracellular staining was carried out using the Cytofix/Cytoperm kit (BD Pharmingen) following a 4 h restimulation by PMA/ionomycin (Sigma) in the presence of GolgiPlug (BD Pharmingen). Flow cytometric data acquisition was performed on a NovoExpress flow cytometer and analyzed with NovoExpress software (ACEA Biosciences).
+ Open protocol
+ Expand
6

Phenotypic Analysis of Influenza-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells were washed twice with cold PBS with 0.5% FBS and 0.1% NaN3 and centrifuged at 1,600 rpm for 5 min at 4°C. Purified rat anti-mouse CD16/CD32 (BD Pharmingen, San Diego, CA, USA) Fc blocker and 5 µg/ml streptavidin (Invitrogen) were added to each sample and incubated for 20 min at 4°C. The following cocktail was used for surface staining: CD3-APC/Cy7 (Clone 17A2; BioLegend), CD8-PE (Clone KT15; MBL Life science, Tokyo, Japan), CD62L-Alexa Fluor 700 (Clone MEL-14; BioLegend), CD69-PE/Cy7 (Clone H1.2F3; BioLegend), CD103-FITC (Clone 2E7; BioLegend) and influenza B-NP specific Dd/NP166-174 (FSPIRITFL) tetramer. The B-NP-specific Dd/NP166-174 (FSPIRITFL) tetramer was produced as described previously (20 (link)). In brief, recombinant Dd protein was refolded in the presence of NP166-174 peptide and β2m, biotinylated with biotin-protein ligase BirA, and then purified with Superdex-75 gel filtration column (GE Healthcare Life science, Chicago, IL, USA). The purified monomer was tetramerized with Alexa Fluor 647-streptavidin conjugates (Thermo Fisher Scientific, Waltham, MA, USA). Stained cells were washed, fixed using BD FACS Lysing Solution (BD Pharmingen) at RT for 20 min, and collected on an LSRFortessa flow cytometer (BD Biosciences). Data were analyzed using Flowjo software (TreeStar Inc., Ashland, OR, USA).
+ Open protocol
+ Expand
7

Flow Cytometric Analysis of T-Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Harvested cells were stained for flow cytometry in PBS for 20 min at RT. The following antibodies were purchased from BioLegend (San Diego, United States) and used for flow cytometric analysis: CD8a-BV510 (cat: 100752, clone: 53-6.7, dilution 1:200), CD45.1-PacificBlue (cat: 110722, clone: A20, dilution 1:200), CD44-APC (cat: 559250, clone: IM7, dilution 1:100), CD11c-PerCP (cat: 117326, clone: N418, dilution 1:200), CD69-PeCy7 (cat: 104512, clone: H1.2F3, dilution 1:100), CD25-FITC (cat: 553072, clone: 3C7, dilution 1:100). The viability of cells was determined by using fixable near-IR dead cell staining (LifeTechnologies, Carlsbad, United States). Biotinylation was assessed by streptavidin-PE (BioLegend) staining for 10 min at RT. T-cell activation was determined by the expression of GFP expression under the control of the Nur77 promoter. Data was acquired on a CantoTM flow cytometer (BD Bioscience, Allschwil, Switzerland) and analyzed using the FlowJo software (Treestar, Ashland, OR, USA) (see Supplementary Fig. 12 for gating strategy).
+ Open protocol
+ Expand
8

Hamster PBMC Isolation and Immune Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hamster PBMCs were isolated from ethylene diamine tetraceticacid (EDTA) whole blood by overlay on a Histopaque®−1077 density cushion and separated according to manufacturer’s instructions. Tissues were processed into single cell suspensions as described previously (Barrigan et al., 2013 (link)). Cells were stimulated for 6 hours with media alone, cell stimulation cocktail (containing PMA-Ionomycin, Biolegend), 1μg/ml SARS-CoV-2 S peptide pool, or Lassa virus (LASV) GPC peptide pool together with 5μg/ml Brefeldin A (Biolegend). Following surface staining with Live/Dead-APC/Cy7, CD4-Alexa700, CD8-FITC, CD94-BV421 and CD69-PeCy7, B220-BV605, CD11b-PerCPCy5.5, and Ly6G-APC (all Biolegend) cells were fixed with 4% paraformaldehyde (PFA). Sample acquisition was performed on a FACSSymphony-A5 (BD), and data analyzed in FlowJo V10. Cell populations were identified by initially gating on Live/Dead negative, doublet negative (SSC-H vs SSC-A). Activation positive responses are presented after subtraction of the background responses detected in the LASV GPC peptide pool-stimulated samples.
+ Open protocol
+ Expand
9

Multicolor Flow Cytometry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mixed cell suspensions were stained for surface markers with combinations of the following antibodies: CD45‐vioblue 450, CD8‐FITC, CD19‐APC (Tonbo, San Diego, CA), HLA‐DR‐FITC, CD3‐viogreen, CD103‐PE (Miltenyi Biotec, Auburn, CA, USA), CD11c‐PerCp‐Cy5.5, CD69‐PE‐Cy7 (Biolegend, San Diego, CA), CD103‐PE‐Cy7, CD4‐PE (eBiosciences, San Diego, CA, USA), CD56‐APC (BD Pharmingen, San Diego, CA, USA). Dead cells were excluded with 7AAD (Southern Biotech) or zombie dye yellow staining (Biolegend). Analysis was performed on 8‐color MACSQuant 10 (Miltenyi biotech) or Gallios (Beckman Coulter) flow cytometers and data were analyzed with FlowJo software (Tree Star, Inc. Ashland, OR, USA). Expression of surface markers is shown as percentage of positive cells and MFI. Fluorescence minus one (FMO) strategy was used to establish appropriate gates. Comparisons between FMO and isotype controls showed no differences. For tissue dendritic cell (DC) quantification, DCs were identified using flow cytometry as CD45+, CD3‐, CD19‐, CD56‐, HLA‐DRhigh, CD11c+ cells as described before (Rodriguez‐Garcia et al., 2017), and the cell number was normalized to tissue weight.
+ Open protocol
+ Expand
10

Multiparameter Flow Cytometry Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The characterization of differentiated MDM was performed via flow cytometry with the following mAbs: CD11b BV 786 (Biolegend, San Diego, CA, USA; clone IRCF44), CD14 APC (BD Biosciences, Franklin Lakes, NJ, USA; clone M5E2), CD206 FITC (BD Biosciences, clone 19.2), HLA-DR BV711 APC (BD Biosciences, clone G46-6), CD16 PE (BD Biosciences, clone 3G8), CD4 BV 421 (BD Biosciences, clone RPA-T4), CD8FITC (BD Biosciences, clone RPA-T8), CD19 APC (BD Biosciences, cloneHIB19) and CD69PECy7 (Biolegend, clone G10F5). Live dead staining (ThermoFisher, Waltham, MA, USA) was performed as a control for vitality. Labelled cells were fixed in PBS−/− 1× 1% formalin. A minimum of 50.000 events were acquired for each sample using a BD Lyric (BD Biosciences) and analyzed by FACS Diva 8.0.1 (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!